Surface Engineering of Liposomes for Stealth Behavior
Open Access
- 25 October 2013
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 5 (4), 542-569
- https://doi.org/10.3390/pharmaceutics5040542
Abstract
Liposomes are used as a delivery vehicle for drug molecules and imaging agents. The major impetus in their biomedical applications comes from the ability to prolong their circulation half-life after administration. Conventional liposomes are easily recognized by the mononuclear phagocyte system and are rapidly cleared from the blood stream. Modification of the liposomal surface with hydrophilic polymers delays the elimination process by endowing them with stealth properties. In recent times, the development of various materials for surface engineering of liposomes and other nanomaterials has made remarkable progress. Poly(ethylene glycol)-linked phospholipids (PEG-PLs) are the best representatives of such materials. Although PEG-PLs have served the formulation scientists amazingly well, closer scrutiny has uncovered a few shortcomings, especially pertaining to immunogenicity and pharmaceutical characteristics (drug loading, targeting, etc.) of PEG. On the other hand, researchers have also begun questioning the biological behavior of the phospholipid portion in PEG-PLs. Consequently, stealth lipopolymers consisting of non-phospholipids and PEG-alternatives are being developed. These novel lipopolymers offer the potential advantages of structural versatility, reduced complement activation, greater stability, flexible handling and storage procedures and low cost. In this article, we review the materials available as alternatives to PEG and PEG-lipopolymers for effective surface modification of liposomes.This publication has 173 references indexed in Scilit:
- Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor TargetingJournal of Drug Delivery, 2013
- Stealth Properties to Improve Therapeutic Efficacy of Drug NanocarriersJournal of Drug Delivery, 2013
- Platelets directed liposomes for the delivery of streptokinase: Development and characterizationEuropean Journal of Pharmaceutical Sciences, 2011
- Stealth nanoparticles: High density but sheddable PEG is a key for tumor targetingJournal of Controlled Release, 2010
- “Clickable”, polymerized liposomes as a versatile and stable platform for rapid optimization of their peripheral compositionsChemical Communications, 2010
- The encapsulation and release of guanosine from PEGylated liposomesJournal of Liposome Research, 2009
- Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to ClinicCritical Reviews in Therapeutic Drug Carrier Systems, 2009
- Cytoplasmic Delivery of Liposomal Contents Mediated by an Acid-Labile Cholesterol-Vinyl Ether-PEG ConjugateBioconjugate Chemistry, 2008
- PegylationClinical Pharmacokinetics, 2001
- Polyethylenglykol-umhülltes (pegyliertes) liposomales DoxorubicinDrugs, 1997